Search

Illumina Inc

Gesloten

SectorGezondheidszorg

269.81 -1.44

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

268.69

Max

275.92

Belangrijke statistieken

By Trading Economics

Inkomsten

-268M

-134M

Verkoop

68M

1.2B

K/W

Sectorgemiddelde

44.473

55.725

EPS

1.31

Winstmarge

-11.562

Werknemers

8,600

EBITDA

80M

330M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

-25.6% downside

Dividenden

By Acuity

Volgende Winsten

29 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

7.4B

36B

Vorige openingsprijs

271.25

Vorige sluitingsprijs

269.81

Nieuwssentiment

By Acuity

42%

58%

89 / 339 Rangschikking in Healthcare

Illumina Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 sep 2026, 23:05 UTC

Illumina Inc's shares traded modestly lower in after-market hours, following a decline from earlier highs, despite strong gains over the past month.

24 sep 2026, 23:06 UTC

Social Media

Illumina Inc is declining in after-market hours after retracing from an earlier peak, despite a recent strong performance above its 20-day moving average.

23 sep 2026, 23:01 UTC

Social Media

Illumina Inc is seeing notable after-market gains following commentary on a new gene-editing mechanism, reflecting volatility after an initial dip earlier in the session.

22 sep 2026, 20:06 UTC

Illumina Inc is advancing, continuing its upward trajectory since Monday, peaking in the late afternoon and remaining above the 20-day moving average.

21 sep 2026, 20:06 UTC

Illumina Inc shares fell modestly after a mid-morning peak, though they remain above the 20-day moving average and near the upper end of their one-month range.

18 sep 2026, 23:06 UTC

Illumina Inc's stock is advancing in after-market trading, supported by mixed economic data and remaining above its 20-day moving average.

17 sep 2026, 23:06 UTC

Illumina Inc is trading modestly higher in after-market hours, supported by strong broader market performance and recent gains over the past month.

16 sep 2026, 23:01 UTC

Illumina Inc. is up in after-market trading, following five consecutive sessions of gains and trading significantly above its 20-day moving average.

15 sep 2026, 23:01 UTC

Illumina Inc's shares are trading higher in after-market hours, benefiting from a broader market rally despite mixed macroeconomic signals.

14 sep 2026, 20:08 UTC

Illumina Inc shares are higher today, though no specific news explains the move. Broader market concerns include rising crude oil prices and inflation.

11 sep 2026, 20:01 UTC

Illumina Inc's shares are higher Friday, continuing an upward trend since Thursday's close. No specific news was identified to explain the movement.

9 sep 2026, 20:07 UTC

Illumina Inc shares are lower today, continuing a decline since Tuesday's close. The stock remains below its 20-day moving average.

8 sep 2026, 23:51 UTC

Illumina Inc shares are higher in after-market trading, showing notable activity and positioning above the 20-day moving average amid a lack of specific news.

5 sep 2026, 00:05 UTC

News

Illumina Inc will join the S&P 500 on September 21, 2026. Shares are advancing in after-market hours following the announcement.

4 sep 2026, 23:02 UTC

News

Illumina Inc will join the S&P 500 index effective September 21, 2026, following an announcement by Dow Jones Indices. Shares are trading higher after the news.

3 sep 2026, 20:07 UTC

News

Illumina shares are higher as analysts raise price targets, with Argus at $235 and Baird at $225, reflecting increased confidence in the company.

2 sep 2026, 22:56 UTC

Illumina Inc's shares are higher in after-market hours following Wednesday's close, maintaining a position above its 20-day moving average. No specific news was identified.

1 sep 2026, 20:09 UTC

Illumina Inc's shares are lower today, continuing a downward trend observed since Monday. The stock has reached a session low, marking a third consecutive decline.

31 aug 2026, 23:36 UTC

Illumina Inc. shares declined in after-market trading, following hawkish comments from Federal Reserve Chair Kevin Warsh that affected market sentiment.

28 aug 2026, 23:16 UTC

Illumina Inc's shares are higher in after-market trading, reflecting positive momentum since Friday's close and routine trading activity within a narrow range.

27 aug 2026, 20:07 UTC

Illumina Inc shares are higher during Thursday's session, supported by a decline in initial jobless claims, though no specific company news was identified.

26 aug 2026, 20:07 UTC

News

Illumina Inc shares are lower today amid a broader downturn in the Life Sciences Tools & Services sub-sector. Analysts estimate fair value at $172.53.

25 aug 2026, 20:07 UTC

News

Illumina Inc shares are advancing as investor sentiment improves ahead of a meeting with Piper Sandler scheduled for August 27.

24 aug 2026, 20:02 UTC

Social Media
News

Illumina Inc reported second-quarter earnings of $1.31 per share, with revenue of $1.16 billion, surpassing estimates. Shares are advancing during Monday's session.

21 aug 2026, 19:16 UTC

Illumina Inc shares are higher today, recovering from earlier losses and remaining above the 20-day moving average for the third consecutive session.

20 aug 2026, 20:02 UTC

Illumina Inc's shares are higher today, building on gains since Wednesday. The stock is trading near the upper end of its one-month range.

19 aug 2026, 20:02 UTC

Correlated Moves

Illumina Inc. shares are higher, buoyed by strong momentum in the genomics sector and a notable rise in the ARK Genomic Revolution ETF.

17 aug 2026, 19:54 UTC

News

Illumina Inc's stock is higher, supported by a Yahoo Finance article discussing its price target of $198.89 and concerns over organic sales performance.

13 aug 2026, 20:06 UTC

Illumina Inc's shares are lower amid declines in the Life Sciences Tools & Services sector, with no specific company news identified for the movement.

12 aug 2026, 22:02 UTC

Illumina Inc shares are lower in after-market hours with no specific news identified. Broader market conditions reflect mixed performance amid inflation data.

Peer Vergelijking

Prijswijziging

Illumina Inc Prognose

Koersdoel

By TipRanks

-25.6% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 200.875 USD  -25.6%

Hoogste 260 USD

Laagste 113 USD

Gebaseerd op 17 Wall Street-analisten die 12-maands prijsdoelen bieden voor Illumina Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

17 ratings

9

Buy

5

Hold

3

Sell

Sentiment

By Acuity

89 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.